USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Global Biosimilars Market: Patent Expiries of Blockbuster Biologics Provide Large Market Opportunity
Vital Signs - Global Biosimilars Market: Patent Expiries of Blockbuster Biologics Provide Large Market Opportunity
RELEASE DATE
20-Jun-2012
20-Jun-2012
REGION
North America
North America
Research Code: 9561-00-E0-00-00
SKU: HC00650-NA-MR_04123
$1,500.00
In stock
SKU
HC00650-NA-MR_04123
Description
This issue of Vital Signs, released on June 20, 2012, provides an insight in to the global biosimilars market.
Additionally, a company spotlight is provided for Dragonfly Sciences. Dragonfly Sciences is a private biotechnology company specializing in the development of biosimilar monoclonal antibodies and soluble receptors. Reimbursement and regulatory news from the FDA is also provided for week of June 4, 2012.
Table of Contents
This week's issue
Popular Topics
This issue of Vital Signs, released on June 20, 2012, provides an insight in to the global biosimilars market. Additionally, a company spotlight is provided for Dragonfly Sciences. Dragonfly Sciences is a private biotechnology company specializing in the development of biosimilar monoclonal antibodies and soluble receptors. Reimbursement and regulatory news from the FDA is also provided for week of June 4, 2012.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-E0-00-00 |
| Is Prebook | No |